Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease. (2014)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jacc.2013.10.070
PubMed Identifier: 24315920
Publication URI: http://europepmc.org/abstract/MED/24315920
Type: Journal Article/Review
Volume: 63
Parent Publication: Journal of the American College of Cardiology
Issue: 9
ISSN: 0735-1097